IOL Chemicals & Pharmaceuticals Ltd

Q3FY23 Quarterly Result Announced for IOL Chemicals and Pharmaceuticals Ltd.

 IOL Chemicals and Pharmaceuticals announced Q3FY23 results:

• Q3FY23:
  • Total income stood at Rs 530 crore against Rs 546 crore QoQ and Rs 564 crore YoY
  • EBITDA at Rs 50 crore as compared to Rs 37 crore QoQ and Rs 68 crore YoY
  • Net profit of the company at Rs 24.15 crore against Rs 15.67 crore QoQ and Rs 40.07 crore YoY
  • Paracetamol capacity expansion by 1,800 MTPA completed
  • Company focusing on frugal manufacturing practices to reduce raw material costs and expand margins

Commenting on the quarterly performance, Dr Sanjay Chaturvedi, Executive Director & CEO said, “The quarterly performance reflects our commitment to control our costs and improve our margin trajectory. For the third quarter, EBITDA and net profit margins – both improved sequentially. Apart from cost rationalisation, we have completed our capacity enhancement of Paracetamol by 1,800 MTPA to take total capacity to 3,600 MTPA with backward integration of Para Amino Phenol (PAP) and we expect this capacity enhancement to boost volume growth from next quarter onwards.”

Result PDF